Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme

Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme

US Patent 10596151 · Granted Mar 24, 2020

Estimated economic value: $14,221,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Absorbent article with side seam bond2025
Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole2023
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors2022
Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-2021
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors2020
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methy2016
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methy2014
Methods, kits and compositions for suppressing the binding of detectable probes 2005
Methods for suppressing the binding of detectable probes to non-target sequences2000
Process for preparing peroxycarboxylic acids using lipase in a non-aqueous mediu1996
Process for decomposing peroxycarboxylic acids1996
Process for producing methyl glycoside esters1993